For Oncology Nurses: Strategies to Safely and Effectively Implement Antibody-Drug Conjugates — Proceedings from the 2026 Annual ONS Congress

Lung Cancer Update · Jul 8, 2026 · 1:28:54

Listen in the Podli app 🎧

Follow your favourite podcasts, listen offline and in the car with CarPlay and Android Auto, and always pick up where you left off. Free to try.

Featuring perspectives from Ms Courtney Arn, Ms Jamie Carroll, Dr Edward B Garon, Dr Heather McArthur and Dr Kathleen N Moore, moderated by Dr Moore, including the following topics:

Introduction (0:00)
Overview of Antibody-Drug Conjugates (ADCs) (2:07)
Current and Future Role of HER2-Targeted ADCs for Breast Cancer (6:23)
Currently Available ADCs for Gynecologic Cancer Management (26:37)
Currently Available ADCs for Lung Cancer Management (44:07)
Current and Future Role of TROP2-Targeted ADCs for Metastatic Breast Cancer (56:55)
Other ADCs That May Soon Reach the Clinic for Advanced Gynecologic Cancers (1:15:07)
Promising Investigational Strategies Employing ADCs for Lung Cancer (1:25:01)

NCPD information and select publications